Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study

Background. Nonmotor symptoms (NMS) are common in advanced Parkinson’s disease (APD) and reduce health-related quality of life. Objective. The aim of the study was to evaluate levodopa-carbidopa intestinal gel (LCIG) versus optimized medical treatment (OMT) on NMS in APD. Methods. INSIGHTS was a pha...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Parkinson's disease Ročník 2022; číslo 1; s. 1216975
Hlavní autoři:	Chung, Sun Ju, Calopa, Matilde, Ceravolo, Maria G., Tambasco, Nicola, Antonini, Angelo, Chaudhuri, K. Ray, Robieson, Weining Z., Sánchez-Soliño, Olga, Zadikoff, Cindy, Jin, Man, Barbato, Luigi M.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Hindawi 2022 John Wiley & Sons, Inc Wiley
Témata:	Carbidopa Comparative analysis Dopa Dopamine Drug dosages Dyskinesia FDA approval Health aspects Intestine Levodopa Medical research Medical treatment Medicine, Experimental Movement disorders Neurodegenerative diseases Parkinson's disease Patients Peripheral neuropathy Quality of life Sleep
ISSN:	2090-8083, 2042-0080
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!